Learn more about our work in the highlighted research areas
Understand cancer, develop new drugs and personalize treatment with Genevia Technologies.
Our history in cancer bioinformatics is long: we have had the privilege to work with biologists seeking for a deeper understanding of cancer, companies developing new treatments to cancer, as well as oncologists wishing to optimize therapies to individual patients.
Research into the development, function and pathologies of the nervous system deserves the best bioinformatics support.
Whether you are tracking the development of the brain in mice, studying a neuropathology with iPSC-derived neurons or characterizing the microenvironment of CNS tumors, we ensure you get the most out of your ‘omics data.
Explore microbial functions, communities and interactions.
How does the genomic composition of microbes affect their functions and cross-species interactions? How can that information be used to discover new treatments or industrial applications?
Characterize cell types, immune repertoires and mechanisms of immune evasion at the highest resolution.
What are the key cell types that bring about an immune response? How do they develop? How do they malfunction in autoimmune diseases? And how can the immune system be leveraged to treat cancer?
Discover drug targets, mechanisms and biomarkers with cutting-edge omics data analysis.
Molecular measurements based on next-generation sequencing (NGS) and mass-spectrometry (MS) are routinely used throughout the drug development process.
Leave your email address here with a brief description of your needs, and we will contact you to get things moving forward!